Language models guide improvements to seven antibodies
Two rounds of laboratory evolution, using at most 20 variants per antibody, improved the affinity of four mature antibodies by up to sevenfold and three immature ones by up to 160-fold. Biochemical and pseudovirus tests; no demonstration of therapeutic benefit in humans.
Technology: Protein language models
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Language-model-guided variants of seven antibodies were made in two lab evolution rounds (at most 20 variants per antibody) and binding was measured by biolayer interferometry; four antibodies were also checked for thermostability, polyspecificity and pseudovirus neutralization.
- Still unknown: The authors state that affinity gains are smaller than in vivo somatic hypermutation, the method improves existing binding rather than creating new binders, and it may work less well under other selection pressures; no therapeutic benefit in humans is shown.
- AI role: General protein language models guided affinity maturation by choosing which antibody variants to test.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10869273/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41587-023-01763-2&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 481 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.